{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:47:48Z","timestamp":1782733668937,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874187"],"award-info":[{"award-number":["81874187"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11596-026-00181-0","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:48:59Z","timestamp":1777272539000},"page":"771-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["E2F Accelerates the Proliferation of B-Cell Non-Hodgkin Lymphomas by Upregulating Cell-Cycle Genes"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-0906","authenticated-orcid":false,"given":"Si-ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4632-9051","authenticated-orcid":false,"given":"De-dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9442-2009","authenticated-orcid":false,"given":"Jia-si","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"181_CR1","doi-asserted-by":"crossref","unstructured":"Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, et al. Non-Hodgkin lymphoma. Bmj. 2018:k3204.","DOI":"10.1136\/bmj.k3204"},{"issue":"6","key":"181_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/bjh.15764","volume":"185","author":"MS Cairo","year":"2019","unstructured":"Cairo MS, Beishuizen A. Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol. 2019;185(6):1021\u20131042.","journal-title":"Br J Haematol."},{"issue":"1","key":"181_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-024-01570-5","volume":"17","author":"JA Ferry","year":"2024","unstructured":"Ferry JA, Hill B, Hsi ED. Mature B, T and NK-cell, plasma cell and histiocytic\/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification. J Hematol Oncol. 2024;17(1):51.","journal-title":"J Hematol Oncol."},{"issue":"8","key":"181_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.6004\/jnccn.2020.7608","volume":"18","author":"PD Harker-Murray","year":"2020","unstructured":"Harker-Murray PD, Pommert L, Barth MJ. Novel therapies potentially available for pediatric B-cell non-Hodgkin lymphoma. J Natl Compr Canc Netw. 2020;18(8):1125\u20131134.","journal-title":"J Natl Compr Canc Netw."},{"issue":"6","key":"181_CR5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjh.15734","volume":"185","author":"G Egan","year":"2019","unstructured":"Egan G, Goldman S, Alexander S. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies. Br J Haematol. 2019;185(6):1071\u20131085.","journal-title":"Br J Haematol."},{"issue":"1","key":"181_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12943-024-02123-7","volume":"23","author":"S Z\u00f6phel","year":"2024","unstructured":"Z\u00f6phel S, K\u00fcchler N, Jansky J, et al. CD16+ as predictive marker for early relapse in aggressive B-NHL\/DLBCL patients. Mol Cancer. 2024;23(1):210.","journal-title":"Mol Cancer."},{"key":"181_CR7","doi-asserted-by":"publisher","first-page":"1397303","DOI":"10.3389\/fimmu.2024.1397303","volume":"15","author":"Y Gao","year":"2024","unstructured":"Gao Y, Qiao X, Liu Z, et al. The role of E2F2 in cancer progression and its value as a therapeutic target. Front Immunol. 2024;15:1397303.","journal-title":"Front Immunol."},{"key":"181_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2023.03.004","volume":"92","author":"A Kassab","year":"2023","unstructured":"Kassab A, Gupta I, Moustafa AA. Role of E2F transcription factor in oral cancer: Recent insight and advancements. Semin Cancer Biol. 2023;92:28\u201341.","journal-title":"Semin Cancer Biol."},{"issue":"10","key":"181_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.31083\/j.fbl2910360","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hu H, Liu H, et al. Study of the role of E2F1 and TMEM132A in prostate cancer development. Front Biosci (Landmark Ed). 2024;29(10):360.","journal-title":"Front Biosci (Landmark Ed)."},{"key":"181_CR10","doi-asserted-by":"publisher","first-page":"107377","DOI":"10.1016\/j.phrs.2024.107377","volume":"208","author":"N Liu","year":"2024","unstructured":"Liu N, Wang S, Li M, et al. BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer. Pharmacol Res. 2024;208:107377.","journal-title":"Pharmacol Res."},{"issue":"14","key":"181_CR11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1080\/15384101.2015.1056421","volume":"14","author":"MW Musia\u0142ek","year":"2015","unstructured":"Musia\u0142ek MW, Rybaczek D. Behavior of replication origins in Eukaryota\u2013spatio-temporal dynamics of licensing and firing. Cell Cycle. 2015;14(14):2251\u20132264.","journal-title":"Cell Cycle."},{"issue":"3","key":"181_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/epigenomes8030026","volume":"8","author":"A Kim","year":"2024","unstructured":"Kim A, Benavente CA. Oncogenic roles of UHRF1 in cancer. Epigenomes. 2024;8(3):26.","journal-title":"Epigenomes."},{"issue":"4","key":"181_CR13","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.21037\/tcr-23-2145","volume":"13","author":"Y Teng","year":"2024","unstructured":"Teng Y, Liu R. E2F-mediated POLA2 upregulation is correlated with macrophage infiltration and poor prognosis in hepatocellular carcinoma. Transl Cancer Res. 2024;13(4):1848\u20131860.","journal-title":"Transl Cancer Res."},{"issue":"2","key":"181_CR14","doi-asserted-by":"publisher","first-page":"e3671","DOI":"10.1002\/jgm.3671","volume":"26","author":"Z Guo","year":"2024","unstructured":"Guo Z, Zhao Y, Xu M, et al. Natural killer cell-based signature: Prognostic analysis in head and neck squamous cell carcinoma. J Gene Med. 2024;26(2):e3671.","journal-title":"J Gene Med."},{"issue":"2","key":"181_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11010-024-05063-4","volume":"480","author":"J Wei","year":"2025","unstructured":"Wei J, Gao C, Lu C, et al. The E2F family: a ray of dawn in cardiomyopathy. Mol Cell Biochem. 2025;480(2):825\u2013839.","journal-title":"Mol Cell Biochem."},{"issue":"12","key":"181_CR16","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1182\/bloodadvances.2025016180","volume":"9","author":"M Verd\u00fa-Bou","year":"2025","unstructured":"Verd\u00fa-Bou M, Baptista MJ, Ribeiro ML, et al. The role of miR-150-5p\/E2F3\/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential. Blood Adv. 2025;9(12):2953\u20132967.","journal-title":"Blood Adv."},{"issue":"3","key":"181_CR17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1074\/jbc.M808080200","volume":"284","author":"LC Spender","year":"2009","unstructured":"Spender LC, Inman GJ. TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1. J Biol Chem. 2009;284(3):1435\u20131442.","journal-title":"J Biol Chem."},{"key":"181_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","volume":"443","author":"B Xie","year":"2019","unstructured":"Xie B, Wang S, Jiang N, et al. Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56\u201366.","journal-title":"Cancer Lett."},{"key":"181_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.breast.2021.12.005","volume":"61","author":"D Petrova","year":"2022","unstructured":"Petrova D, Cruz M, S\u00e1nchez MJ. BRCA1\/2 testing for genetic susceptibility to cancer after 25 years: a scoping review and a primer on ethical implications. Breast. 2022;61:66\u201376.","journal-title":"Breast."},{"issue":"9","key":"181_CR20","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3390\/cells12091344","volume":"12","author":"XTR Moore","year":"2023","unstructured":"Moore XTR, Gheghiani L, Fu Z. The role of polo-like kinase 1 in regulating the forkhead box family transcription factors. Cells. 2023;12(9):1344.","journal-title":"Cells."},{"issue":"7","key":"181_CR21","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3390\/molecules26071981","volume":"26","author":"NA Borah","year":"2021","unstructured":"Borah NA, Reddy MM. Aurora kinase B inhibition: a potential therapeutic strategy for cancer. Molecules. 2021;26(7):1981.","journal-title":"Molecules."},{"key":"181_CR22","doi-asserted-by":"crossref","unstructured":"Jostes S, Vardabasso C, Dong J, et al. H2A.Z chaperones converge on E2F target genes for melanoma cell proliferation. Genes Dev. 2024;38(7\u20138):336\u2013353.","DOI":"10.1101\/gad.351318.123"},{"issue":"14","key":"181_CR23","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s00018-019-03070-z","volume":"76","author":"S Gao","year":"2019","unstructured":"Gao S, Song Q, Liu J, et al. E2F1 mediates the downregulation of POLD1 in replicative senescence. Cell Mol Life Sci. 2019;76(14):2833\u20132850.","journal-title":"Cell Mol Life Sci."},{"issue":"6","key":"181_CR24","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1105\/TPC.010004","volume":"13","author":"EM Egelkrout","year":"2001","unstructured":"Egelkrout EM, Robertson D, Hanley-Bowdoin L. Proliferating cell nuclear antigen transcription is repressed through an E2F consensus element and activated by geminivirus infection in mature leaves. Plant Cell. 2001;13(6):1437\u20131452.","journal-title":"Plant Cell."},{"issue":"14","key":"181_CR25","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1038\/sj.onc.1202544","volume":"18","author":"K Ohtani","year":"1999","unstructured":"Ohtani K, Iwanaga R, Nakamura M, et al. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene. 1999;18(14):2299\u20132309.","journal-title":"Oncogene."},{"issue":"6","key":"181_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326\u2013338.","journal-title":"Nat Rev Cancer."},{"issue":"6","key":"181_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3390\/cancers15061905","volume":"15","author":"M Gola","year":"2023","unstructured":"Gola M, Stefaniak P, Godlewski J, et al. Prospects of POLD1 in human cancers: a review. Cancers. 2023;15(6):1905.","journal-title":"Cancers."},{"issue":"14","key":"181_CR28","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.7150\/ijbs.64628","volume":"17","author":"S Zhang","year":"2021","unstructured":"Zhang S, Zhou T, Wang Z, et al. Post-translational modifications of PCNA in control of DNA synthesis and DNA damage tolerance-the implications in carcinogenesis. Int J Biol Sci. 2021;17(14):4047\u20134059.","journal-title":"Int J Biol Sci."},{"issue":"1","key":"181_CR29","doi-asserted-by":"publisher","first-page":"168276","DOI":"10.1016\/j.jmb.2023.168276","volume":"436","author":"A Sallmyr","year":"2024","unstructured":"Sallmyr A, Bhandari SK, Naila T, et al. Mammalian DNA ligases; roles in maintaining genome integrity. J Mol Biol. 2024;436(1):168276.","journal-title":"J Mol Biol."},{"issue":"1","key":"181_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells14010012","volume":"14","author":"A Malysa","year":"2024","unstructured":"Malysa A, Zhang XM, Bepler G. Minichromosome maintenance proteins: from DNA replication to the DNA damage response. Cells. 2024;14(1):12.","journal-title":"Cells."},{"issue":"12","key":"181_CR31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/biology12121511","volume":"12","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Nakajima R, Shirasawa M, et al. Expanding roles of the E2F-RB-p53 pathway in tumor suppression. Biology. 2023;12(12):1511.","journal-title":"Biology."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-026-00181-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:35:45Z","timestamp":1782732945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-026-00181-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1007\/s11596-026-00181-0","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was reviewed and approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Approval No. 2020-S207).\u00a0Written informed consent was obtained from the legal guardians of all participating children for the use of clinical samples and associated data.\u00a0For datasets obtained from public repositories (GEO, TCGA), all original studies had obtained appropriate ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Written consent for publication was obtained from the legal guardians of all participating children.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}